Top Biotechnology companies in Taiwan by Debt to Equity Ratio

This ranking features the top 23 Biotechnology companies in Taiwan ranked by Debt to Equity Ratio, averaging a Debt to Equity Ratio of 0.29, for February 05, 2025.
#
Name
Debt to Equity Ratio
Reported Date
Stock Price
Change
Price (30 days) Country
1
1.42
Dec. 31, 2023 USD 2.07 NA

Taiwan

2
0.81
Dec. 31, 2023 USD 1.34 NA

Taiwan

3
0.67
Dec. 31, 2023 USD 7.84 NA

Taiwan

4
0.54
Dec. 31, 2023 USD 2.22 NA

Taiwan

5
0.51
Dec. 31, 2023 USD 1.58 NA

Taiwan

6
0.38
Dec. 31, 2023 USD 2.64 NA

Taiwan

7
0.29
Dec. 31, 2023 USD 2.60 NA

Taiwan

8
0.28
Dec. 31, 2023 USD 1.24 NA

Taiwan

9
0.28
Dec. 31, 2023 USD 3.66 NA

Taiwan

10
0.25
Dec. 31, 2023 USD 1.26 NA

Taiwan

11
0.25
Dec. 31, 2023 USD 1.87 NA

Taiwan

12
0.22
Dec. 31, 2023 USD 0.69 NA

Taiwan

13
0.17
Dec. 31, 2023 USD 2.59 NA

Taiwan

14
0.13
Dec. 31, 2023 USD 1.81 NA

Taiwan

15
0.08
Dec. 31, 2023 USD 0.62 NA

Taiwan

16
0.07
Dec. 31, 2023 USD 0.34 NA

Taiwan

17
0.06
Dec. 31, 2023 USD 0.68 NA

Taiwan

18
0.05
Dec. 31, 2023 USD 0.97 NA

Taiwan

19
0.04
Dec. 31, 2023 USD 0.61 NA

Taiwan

20
0.03
Dec. 31, 2023 USD 2.34 NA

Taiwan

21
0.01
Dec. 31, 2023 USD 0.49 NA

Taiwan

22
0.01
Dec. 31, 2023 USD 0.95 NA

Taiwan

23
0.00
Dec. 31, 2023 USD 3.03 NA

Taiwan

Frequently Asked Questions
  • Which Biotechnology company in Taiwan has the highest Debt to Equity Ratio ?

    The Biotechnology company in Taiwan with the highest Debt to Equity Ratio is Bionime Corporation (Taiwan Stock Exchange: 4737.TW) at 1.42.

  • Which Biotechnology company in Taiwan has the lowest Debt to Equity Ratio ?

    The Biotechnology company in Taiwan with the lowest Debt to Equity Ratio is PharmaEngine, Inc. (Taipei Exchange: 4162.TWO) at 0.00.

SV Wall Street